These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6128922)

  • 1. Influencing drug use through prescribing restrictions.
    Huber SL; Patry RA; Hudson HD
    Am J Hosp Pharm; 1982 Nov; 39(11):1898-901. PubMed ID: 6128922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted cephalosporin use in teaching hospitals.
    Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1981 Apr; 38(4):513-7. PubMed ID: 7282677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial.
    Pimlott NJ; Hux JE; Wilson LM; Kahan M; Li C; Rosser WW
    CMAJ; 2003 Apr; 168(7):835-9. PubMed ID: 12668540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing the prescribing of antimicrobial agents without a formulary system.
    Ham CW
    Am J Hosp Pharm; 1992 Dec; 49(12):2909, 2914. PubMed ID: 1481790
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic restriction in hospitals associated with medical schools.
    Klapp DL; Ramphal R
    Am J Hosp Pharm; 1983 Nov; 40(11):1957-60. PubMed ID: 6650526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
    Drexler PG; Lambdin CS
    J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.
    Lautenbach E; LaRosa LA; Marr AM; Nachamkin I; Bilker WB; Fishman NO
    Clin Infect Dis; 2003 Feb; 36(4):440-6. PubMed ID: 12567301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of rational drug use and prescribing in primary health care facilities in north west Ethiopia.
    Desta Z; Abula T; Beyene L; Fantahun M; Yohannes AG; Ayalew S
    East Afr Med J; 1997 Dec; 74(12):758-63. PubMed ID: 9557418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of early or late implementation of prior authorization policies on the use of Cox II inhibitors.
    Roughead EE; Zhang F; Ross-Degnan D; Soumerai S
    Med Care; 2006 Apr; 44(4):378-82. PubMed ID: 16565640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.
    Aspinall SL; Metlay JP; Maselli JH; Gonzales R
    Am J Manag Care; 2007 May; 13(5):241-8. PubMed ID: 17488189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.